LiveFeed

Biotech Catalyst Alerts

LiveFeed keeps biotech market alerts moving in one continuous stream, pairing with the PDUFA calendar so you can follow FDA updates, PDUFA-related headlines, clinical results, company news, and other catalyst events with precise EST timestamps and one-tap article access.

Filter

Filter the feed by exact ticker symbols or keyword tags, then apply the selection to the live list. Free users can save 1 ticker and 1 keyword filter. Pro users can save up to 5 tickers and 5 keywords, while Ultra users have no limit.

07/28/2026 (Tuesday)
ENLV
Enlivex Announces $400,000,000 Private PlacementNes-Ziona, Israel, July 28, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV, "Enlivex" or "the Company"), a quality longevity company powered by a...
XRAY
Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair RelationshipMedline Sinclair to Offer Dentsply Sirona's Full Technology Portfolio Across Canada...
RLMD
Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business OfficerBrings nearly three decades of leadership spanning NMIBC, corporate strategy and business development to help advance NDV-01 and support the…...
RIGL
Rigel Announces Conference Call and Webcast to Report Second Quarter 2026 Financial Results, /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its second quarter 2026 financial results after marke...
GSK
GSK to establish new flagship R&D centre on Cambridge Biomedical Campus, UKInvestment further integrates company into world-class ecosystem of biomedical research, patient care and academia
LEGN
Legend Biotech to Host Investor Conference Call on Second Quarter 2026 ResultsLegend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will...
UNH
Corbus Pharmaceuticals Announces FDA Clearance to Initiate TEMPO-1 Registrational Study of CRB-701 in Patients with 2L Oropharyngeal CancerCompany expects to initiate enrollment in TEMPO-1 in September 2026 OPSCC is estimated to represent 1 in 2 head and neck cancer patients in the…...
BCLI
BrainStorm Appoints Former FDA Associate Commissioner Peter J. Pitts as Executive ChairmanProfessor Jacob Frenkel Transitions to Senior Advisor Peter J. Pitts to lead NurOwn® into Phase 3b trial; advancing under the first Special Protocol A...
GSK
GSK delivers strong Q2 core results performance and continued momentum. Plans announced to accelerate R&D and late-stage pipeline portfolio. Expect 20+ phase III trial starts in 202628 July 2026For media and investors only ​Issued: London, UKDownload (PDF - 967.3KB)Strong Specialty Medicines and Vaccines performance drives sales a...
GSK
GSK’s licensor Hansoh Pharma announces positive results from a second phase III trial for Ris-Rez in ChinaARTEMIS-011, a phase III study conducted for China, met its primary endpoint of progression-free survival in relapsed osteosarcoma